"10.1371_journal.pone.0071957","plos one","2013-08-05T00:00:00Z","Patricia Kreis; Rita Hendricusdottir; Louise Kay; Ismini E Papageorgiou; Michiel van Diepen; Till Mack; Jonny Ryves; Adrian Harwood; Nicholas R Leslie; Oliver Kann; Maddy Parsons; Britta J Eickholt","MRC Centre for Developmental Neurobiology, Kings College London, London, United Kingdom; Department of Pharmacology, University of Oxford, Oxford, United Kingdom; Institute of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany; Novartis Pharmaceuticals UK Limited, Horsham, United Kingdom; Cluster of Excellence NeuroCure and Institute of Biochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cardiff School of Biosciences, Cardiff University, Cardiff, United Kingdom; College of Life Sciences, University of Dundee, Dundee, United Kingdom; Randall Division of Cell and Molecular Biophysics, Kings College London, London, United Kingdom","Conceived and designed the experiments: PK IEP MvD NRL OK BJE. Performed the experiments: PK RH LK IEP MvD TM JR MP. Analyzed the data: PK IEP MvD TM MP. Contributed reagents/materials/analysis tools: JR AH NRL. Wrote the manuscript: PK BJE.","Michiel van Diepen is an employee of Novartis. He moved to Novartis after the contract with Kings College, and the authors would like to confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Patricia Kreis","PK",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
